1. Somsen GA1, Verberne HJ, Fleury E, Righetti A. Normal values and within-subject variability of cardiac I-123 MIBG scintigraphy in healthy individuals: implications for clinical studies. J Nucl Cardiol. 2004 Mar-Apr;11(2):126-33.

2. Pizzi MN1, Sabaté-Fernández M, de León G, Aguadé-Bruix S, Candell-Riera J. False heart-to-mediastinum ratio of I-123 metaiodobenzylguanidine due to right ventricular attenuation. Clin Nucl Med. 2011 Sep;36(9):828-30.

3. Sang Yong Ji MD, Mark I. Travin MD. Radionuclide imaging of cardiac autonomic innervation. Journal of Nuclear Cardiology 2010, Volume 17, Issue 4, pp 655-666

4. Marini C1, Bandettini di Poggio M, Pomposelli E, Marchese R, Nobili F, Morbelli SD, Villa G, Abbruzzese G, Sambuceti G. Whole body and cardiac metaiodobenzylguanidine kinetics in Parkinson disease and multiple system atrophy:
implications for the diagnostic role of imaging. Clin Nucl Med. 2010 May;35(5):311-6.

5. Treglia G1, Stefanelli A, Cason E, Cocciolillo F, Di Giuda D, Giordano A.. Diagnostic performance of iodine-123-metaiodobenzylguanidine scintigraphy in differential diagnosis between Parkinson's disease and multiple-system atrophy: a systematic review and a meta-analysis. Clin Neurol Neurosurg. 2011 Dec;113(10):823-9.

감사합니다.


=====================================답변========================================
이메일로 발송 완료